Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gubra ASFRA:PI3 -1.33%68 3-Year Book Growth Rate is 119.70% as of Jun. 2026, which is 90% above its 10-year median of 62.90. GuruFocus rates FRA:PI3 with a GF Score™ of 68/100 and a GF Value™ of €27.06 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 1,126 Biotechnology companies, Gubra AS ranks better than 98.67% on this metric.
During the past 12 months, Gubra AS's average Book Value per Share Growth Rate was -14.30% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 119.70% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 67.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 7 years, the highest 3-Year average Book Value per Share Growth Rate of Gubra AS was 119.70% per year. The lowest was 19.30% per year. And the median was 62.90% per year.
Gubra AS (FRA:PI3) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Gubra AS 3-Year Book Growth Rate Related Terms
FRA:PI3 vs VRTX, REGN, MRNA: 3-Year Book Growth Rate Comparison
For the Biotechnology subindustry, Gubra AS's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gubra AS 3-Year Book Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Gubra AS's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Gubra AS's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 119.70% mean?
Gubra AS (FRA:PI3) has a 3-Year Book Growth Rate of 119.70% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Gubra AS and its competitors. This is 90% above median its historical median of 62.90. Over the past decade, Gubra AS's 3-Year Book Growth Rate has ranged from 19.30 to 119.70. According to the industry distribution chart, Gubra AS ranks #15 out of 1126 companies in the Biotechnology industry, placing it in the top 1.3%.
Is Gubra AS's 3-Year Book Growth Rate too high?
Gubra AS's current 3-Year Book Growth Rate of 119.70% is 90% above median its 10-year median of 62.90. Over the past 10 years, this metric has ranged from a low of 19.30 to a high of 119.70. Based on the distribution chart, Gubra AS ranks #15 out of 1126 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Gubra AS has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gubra AS's 3-Year Book Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gubra AS ranks #15 out of 1126 companies for 3-Year Book Growth Rate. This places Gubra AS in the top 1% of its industry — outperforming the majority of peers. Historically, Gubra AS's own 3-Year Book Growth Rate has ranged from 19.30 to 119.70 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Biotechnology company?
A good 3-Year Book Growth Rate depends on the Biotechnology industry context. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Gubra AS and its competitors. Gubra AS's current 3-Year Book Growth Rate is 119.70%, which is 90% above median its own 10-year median of 62.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gubra AS stock overvalued right now?
Based on GuruFocus' analysis, Gubra AS (FRA:PI3) is currently considered Significantly Overvalued. The stock's GF Value™ is €27.06, compared to a current price of €47.50 — trading 75.5% above its estimated fair value. The current 3-Year Book Growth Rate is 119.70%, which is 90% above median its 10-year median of 62.90. Gubra AS's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Gubra AS (FRA:PI3), the current 3-Year Book Growth Rate is 119.70% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gubra AS (FRA:PI3) Overvalued in 2026?
Based on GuruFocus' analysis, Gubra AS stock appears to be overvalued.
The current stock price of €47.50 is trading 75.5% above its estimated GF Value™ of €27.06.
GuruFocus considers Gubra AS to be Significantly Overvalued.
Key valuation signals for FRA:PI3:
3-Year Book Growth Rate: 119.70% (90% above median its 10-year median of 62.90)
GF Value™: €27.06 vs. price of €47.50 (75.5% above fair value)
No single metric tells the full story. See the FRA:PI3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
68GF Score
Get the complete analysis for FRA:PI3
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PI3 has been successfully added to your 
